
Astria Therapeutics
Astria Therapeutics, Inc.: A clinical-stage biopharmaceutical company developing treatments for rare diseases and lipid disorders.
- 24
- Public
Founded in Cambridge, United States, Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutic treatments for rare diseases and serious lipid disorders. With a mission centered around patient care, Astria Therapeutics aims to bring life-changing therapies to individuals and families affected by allergic and immunological diseases.
Notable figures affiliated with Astria Therapeutics include experts in biopharmaceutical development and rare disease treatment. The company has achieved significant milestones in advancing its clinical pipeline and has garnered attention from key investors in the biotech sector. Astria's impact is marked by its commitment to addressing unmet medical needs and improving the quality of life for patients with rare conditions.
Similar Companies

Amicus Therapeutics
amicusrx.com

Aristea Therapeutics
aristeatx.com

Alexion Pharmaceuticals
alexion.com

Star Therapeutics

Harmony Biosciences
Triplet Therapeutics
triplettx.com

Catalyst Pharmaceuticals
catalystpharma.com

Kymera Therapeutics
kymeratx.com

Amylyx Pharmaceuticals
amylyx.com

Ovid Therapeutics
ovidrx.com

Assertio Holdings

Atossa Therapeutics

Arcutis Biotherapeutics
arcutis.com

Lumos Pharma
lumos-pharma.com

Ashvattha Therapeutics
avttx.com
Quick Facts
Who are Astria Therapeutics' competitors?
Companies similar to Astria Therapeutics include Amicus Therapeutics, Aristea Therapeutics, Alexion Pharmaceuticals and Star Therapeutics.
When was Astria Therapeutics founded?
Astria Therapeutics was founded in 2008.
Where is Astria Therapeutics' headquarters located?
Astria Therapeutics' headquarters is located in Boston, MA, US.
When was Astria Therapeutics' last funding round?
Astria Therapeutics' most recent funding round was for $125M (USD) in January 2024.
How much disclosed funding has Astria Therapeutics raised?
As of Jan 30, 2024, Astria Therapeutics has disclosed funding of $656.4M (USD). Undisclosed round amounts are excluded.
How many employees does Astria Therapeutics have?
Astria Therapeutics has 24 employees as of Feb 6, 2024.
Classification
- Customer
- Main Product
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 620000Health Care and Social Assistance
- 541000Professional, Scientific, and Technical Services
- 623000Nursing and Residential Care Facilities
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research